Analyst Ratings for Ionis Pharmaceuticals (IONS) [Sells]
IONS Rating Summary
IONS Price Target Summary
- Highest: $84.00 (Needham & Company)
- Lowest: $35.00 (Morgan Stanley)
- Average: $59.04
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$59.04 (+61.6%)
* Over Last 12-Mos
Rating Score: 4 / 10
Percentile Rank: 37%
Rating Score: 4 / 10
Percentile Rank: 37%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/7/2019 | Morgan Stanley » Updated 5/6/2021 |
David Lebowitz | Downgrade | Underweight (Equalweight) |
35.00 (38.00) |
54.39 (36.54) |
-32.82% | Details |
| 10/6/2017 | Goldman Sachs » Updated 8/28/2018 |
Salveen Richter | New Coverage | Sell (N/A) |
36.00 (N/A) |
56.01 (36.54) |
-34.76% | Details |
